The Chemours Company (NYSE:CC) Receives Average Recommendation of “Hold” from Analysts

The Chemours Company (NYSE:CCGet Free Report) has been assigned a consensus rating of “Hold” from the twelve research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $24.10.

A number of equities research analysts recently weighed in on the stock. Alembic Global Advisors restated an “overweight” rating and issued a $30.00 target price on shares of Chemours in a report on Wednesday, May 13th. UBS Group lifted their price target on Chemours from $29.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, May 8th. Morgan Stanley boosted their price objective on Chemours from $17.00 to $21.00 and gave the stock an “equal weight” rating in a report on Monday, May 11th. Weiss Ratings reissued a “sell (d)” rating on shares of Chemours in a research note on Monday, April 20th. Finally, Zacks Research upgraded Chemours from a “strong sell” rating to a “hold” rating in a report on Friday, April 24th.

View Our Latest Stock Report on Chemours

Institutional Trading of Chemours

Institutional investors have recently made changes to their positions in the company. Atlas Capital Advisors Inc. purchased a new stake in shares of Chemours in the fourth quarter valued at about $26,000. Aster Capital Management DIFC Ltd purchased a new position in Chemours during the fourth quarter worth about $28,000. Covestor Ltd boosted its holdings in Chemours by 204.7% during the fourth quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock worth $31,000 after purchasing an additional 1,748 shares during the last quarter. Eurizon Capital SGR S.p.A. bought a new stake in Chemours in the 4th quarter worth about $31,000. Finally, Rothschild Investment LLC increased its stake in Chemours by 87.0% in the 4th quarter. Rothschild Investment LLC now owns 2,698 shares of the specialty chemicals company’s stock valued at $32,000 after buying an additional 1,255 shares during the last quarter. Institutional investors own 76.26% of the company’s stock.

Chemours Stock Performance

CC opened at $20.12 on Thursday. Chemours has a 1-year low of $10.44 and a 1-year high of $28.67. The company has a market cap of $3.03 billion, a price-to-earnings ratio of -7.62 and a beta of 1.41. The company’s fifty day moving average price is $22.70 and its two-hundred day moving average price is $19.20. The company has a current ratio of 1.82, a quick ratio of 0.87 and a debt-to-equity ratio of 18.98.

Chemours (NYSE:CCGet Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.10. The firm had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.40 billion. Chemours had a negative net margin of 6.82% and a positive return on equity of 52.49%. The business’s revenue was up 1.0% on a year-over-year basis. During the same period last year, the company earned $0.13 earnings per share. On average, analysts expect that Chemours will post 1.07 EPS for the current fiscal year.

Chemours Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Sunday, May 17th were given a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend was Friday, May 15th. Chemours’s dividend payout ratio is presently -13.26%.

About Chemours

(Get Free Report)

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.

Featured Articles

Analyst Recommendations for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.